A Spatially coarse-grained, rule-based frame work for modeling large molecular
用于建模大分子的空间粗粒度、基于规则的框架
基本信息
- 批准号:8503615
- 负责人:
- 金额:$ 32.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-05 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigensCell membraneCellsCerealsComplexCytosolDataDevelopmentEpidermal Growth Factor ReceptorExplosionFc epsilon RIIgEMethodologyMicroscopicModelingMolecularNatureRelative (related person)Signal TransductionSimulateSystemVascular Endothelial Growth Factor ReceptorWorkbasecombinatorialcrosslinkexperiencenetwork modelsreceptorsimulationspatial neglecttool
项目摘要
DESCRIPTION (provided by applicant): The development of mathematical tools to simulate signaling dynamics is extremely important. Based on our previous experimental data and simulation results, we are convinced that to accurately and appropriately model signaling networks, we cannot neglect the spatial organization of the cell membrane (and ultimately the cytosol as well). We have extensive experience in developing spatially realistic simulations of the cell membrane and studied the initiation of signaling. However, while these simulations are extremely computationally intense, crucial aspects of cell signaling can only be correctly represented in the context of the entire cell membrane, or at least a significant portion of it. Th Fc¿RI system presents an additional challenge relative to other commonly studied receptor systems (i.e. EGFR, VEGFR), in that the Fc¿RI/IgE complex essentially behaves as a bivalent receptor, while the antigens are typically multivalent (valency from 3 to ¿24). As a result, arbitrarily large aggregates may emerge through the multivalent cross-linking of FceRI/IgE complexes by the antigen. Due to the combinatorial explosion of the number of possible aggregate types, this problem is eminently suited for the rule-based approach to bio-molecular network modeling. Thus, the nature of the FceRI/IgE system requires the integration of the rule-based approach with a spatial modeling framework. We will develop a coarse grained methodology for integration of detailed (microscopic) and cell-level (mesoscopic) simulations and experimental results. This framework will help address both challenges described above, namely (a) integrate detailed, microscopic simulations and experimental data into a mesoscopic model that captures a significant portion of the cell membrane and (b) provide a mechanism to include spatial mobility and steric constraints for large molecular aggregates in a rule-based, stochastic model of the Fc epsilon RI system.
描述(由适用提供):开发模拟信号动态的数学工具非常重要。基于我们以前的实验数据和仿真结果,我们确信要准确,适当地对信号网络进行建模,我们不能忽略细胞膜的空间组织(最终也是细胞质)。我们在开发细胞膜的空间逼真的模拟方面拥有丰富的经验,并研究了信号传导的启动。但是,尽管这些模拟在计算上非常强烈,但细胞信号的关键方面只能在整个细胞膜的背景下正确表示,或者至少在其中很大一部分。相对于其他常用的受体系统(即eGFR,VEGFR),FC¿RI系统提出了额外的挑战,因为Fc?ri/IgE复合物本质上是双重接收器的表现,而抗原通常是多价(价为3至3至€24的价值)。结果,任意较大的聚集体可以通过抗原的FcERI/IgE配合物的多价交联出现。由于可能的骨料类型数量的组合爆炸,因此此问题非常适合基于规则的生物分子网络建模的方法。这就是FCERI/IGE系统的性质要求将基于规则的方法与空间建模框架集成。我们将开发一种粗糙的方法,用于整合详细的(微观)和细胞级(介观)模拟和实验结果。该框架将有助于解决上述两个挑战,即(a)集成的详细,微观模拟和实验数据纳入介观模型,该模型捕获了细胞膜的很大一部分,并且(b)提供了一种机制,提供了一种机制,可以包括空间迁移率和基于基于规则的,基于规则的,fc eps ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri ri conteric的限制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy S Edwards其他文献
Jeremy S Edwards的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy S Edwards', 18)}}的其他基金
Knowledge Management Center for Illuminating the Druggable Genome
阐明可药物基因组的知识管理中心
- 批准号:
10598542 - 财政年份:2018
- 资助金额:
$ 32.54万 - 项目类别:
A Spatially coarse-grained, rule-based frame work for modeling large molecular
用于建模大分子的空间粗粒度、基于规则的框架
- 批准号:
8446651 - 财政年份:2012
- 资助金额:
$ 32.54万 - 项目类别:
A Spatially coarse-grained, rule-based frame work for modeling large molecular
用于建模大分子的空间粗粒度、基于规则的框架
- 批准号:
8892207 - 财政年份:2012
- 资助金额:
$ 32.54万 - 项目类别:
A Spatially coarse-grained, rule-based frame work for modeling large molecular
用于建模大分子的空间粗粒度、基于规则的框架
- 批准号:
8656139 - 财政年份:2012
- 资助金额:
$ 32.54万 - 项目类别:
Polony Sequencing and the $1000 Genome
Polony 测序和价值 1000 美元的基因组
- 批准号:
7976897 - 财政年份:2010
- 资助金额:
$ 32.54万 - 项目类别:
Polony Sequencing and the $1000 Genome
Polony 测序和价值 1000 美元的基因组
- 批准号:
8324730 - 财政年份:2010
- 资助金额:
$ 32.54万 - 项目类别:
Polony Sequencing and the $1000 Genome
Polony 测序和价值 1000 美元的基因组
- 批准号:
8134450 - 财政年份:2010
- 资助金额:
$ 32.54万 - 项目类别:
相似国自然基金
肿瘤细胞膜内侧抗原外翻的光学分子成像及其靶向治疗
- 批准号:82303620
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于细胞膜蛋白质组学的嵌合抗原受体T细胞治疗T-ALL的新策略及其机制研究
- 批准号:82270236
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于红细胞膜的抗原递送仿生载体及其在肿瘤免疫治疗中的应用探索
- 批准号:31900988
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
细胞膜修饰策略在广谱新抗原特异性TCR-T细胞治疗新模式中的应用与评价
- 批准号:81930080
- 批准年份:2019
- 资助金额:295 万元
- 项目类别:重点项目
兼具抗原及佐剂性仿生纳米肿瘤疫苗的应用及机制研究
- 批准号:81901683
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 32.54万 - 项目类别:
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 32.54万 - 项目类别:
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 32.54万 - 项目类别:
Mucosal immunity to sapovirus in early childhood
幼儿期对沙波病毒的粘膜免疫
- 批准号:
10677051 - 财政年份:2023
- 资助金额:
$ 32.54万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 32.54万 - 项目类别: